Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01299259 · ClinicalTrials.gov registry record · NA
Improving Primary Care Follow-up for Patients With Pelvic Inflammatory Disease
A NA study of Pelvic Inflammatory Disease, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 95
- Enrollment target
- 1
- Study location
NCT01299259: Completed NA study of Pelvic Inflammatory Disease, sponsored by Children's Hospital of Philadelphia.
NCT01299259 is a NA study of Pelvic Inflammatory Disease that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 95 participants, below the 151-participant average among 4 other Pelvic Inflammatory Disease trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01299259, a NA study of Pelvic Inflammatory Disease, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators hypothesize that text message reminders to girls diagnosed with pelvic inflammatory disease (PID) in the emergency department (ED) will improve follow-up to their primary care provider (PCP) after being discharged from the ED.
Conditions Studied
Interventions
- BEHAVIORAL Text Message Reminders
Study Locations (1)
Pennsylvania
- The Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2011-02 |
| Est. Completion | 2014-10 |
| Phase | NA |
What the finished NCT01299259 record still lists
NCT01299259 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 151-participant average among 4 other Pelvic Inflammatory Disease trials with a reported enrollment target (37% lower).
The record links to 1 condition, with Pelvic Inflammatory Disease appearing as the primary indexed condition, and to 1 intervention - of which Text Message Reminders is the first listed.
NCT01299259 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01299259 about?
NCT01299259 is a clinical study titled "Improving Primary Care Follow-up for Patients With Pelvic Inflammatory Disease". The investigators hypothesize that text message reminders to girls diagnosed with pelvic inflammatory disease (PID) in the emergency department (ED) will improve follow-up to their primary care provider (PCP) after being discharged from the ED.
What is the current status of trial NCT01299259?
This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2011-02. Estimated completion is 2014-10.
What conditions does trial NCT01299259 study?
This clinical trial studies the following conditions: Pelvic Inflammatory Disease.
What interventions are being tested in trial NCT01299259?
The interventions under investigation include: Text Message Reminders (BEHAVIORAL).
Who is sponsoring clinical trial NCT01299259?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01299259 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pelvic Inflammatory Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer
RECRUITING · NA
-
Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II
ACTIVE NOT RECRUITING · NA
-
Surgical Success After Laparoscopic vs Abdominal Hysterectomy
COMPLETED · NA
-
The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID)
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03339128 · 95 participants · Phase 2
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
- NCT03509961 · 95 participants · Phase 2
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- NCT03694756 · 95 participants · NA
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer
- NCT04206215 · 95 participants · NA
Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia